Zonisamide Mylan

Zonisamide Viatris is a medicine used to treat patients with partial seizures (epileptic fits starting in one part of the brain), including those who have secondary generalisation (where the seizure subsequently spreads to the whole brain). It is used on its own in newly diagnosed adults and as an ‘add-on’ therapy in adults and children aged six years and above already receiving other anti-epilepsy medicines. Zonisamide Viatris contains the active substance zonisamide and is a ‘generic medicine’. This means that Zonisamide Viatris is similar to a ‘reference medicine’ already authorised in the EU called Zonegran. For more information on generic medicines, see the question-and-answer document [here](https://www.ema.europa.eu/en/documents/other/questions-and-answers-generic-medicines_en.pdf).